Xiuxing Chen

2.0k total citations · 3 hit papers
18 papers, 1.5k citations indexed

About

Xiuxing Chen is a scholar working on Oncology, Molecular Biology and Surgery. According to data from OpenAlex, Xiuxing Chen has authored 18 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 7 papers in Molecular Biology and 6 papers in Surgery. Recurrent topics in Xiuxing Chen's work include Colorectal Cancer Treatments and Studies (4 papers), Cancer Immunotherapy and Biomarkers (4 papers) and Pancreatic and Hepatic Oncology Research (4 papers). Xiuxing Chen is often cited by papers focused on Colorectal Cancer Treatments and Studies (4 papers), Cancer Immunotherapy and Biomarkers (4 papers) and Pancreatic and Hepatic Oncology Research (4 papers). Xiuxing Chen collaborates with scholars based in China. Xiuxing Chen's co-authors include Lei Zhou, Lei Fan, De‐Shen Wang, Jie‐Ying Liang, Yuhong Li, Hui Yang, Haocheng Lin, Yun Zheng, Qiyou Wang and Zhengnan Zhou and has published in prestigious journals such as ACS Nano, PLoS ONE and Biomaterials.

In The Last Decade

Xiuxing Chen

18 papers receiving 1.5k citations

Hit Papers

A Novel Ferroptosis-related Gene Signature for Overall Su... 2018 2026 2020 2023 2020 2018 2022 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiuxing Chen China 11 569 379 378 370 362 18 1.5k
Maria Laura Falchetti Italy 26 664 1.2× 233 0.6× 167 0.4× 143 0.4× 136 0.4× 49 1.5k
Xinchi Jiang China 23 908 1.6× 237 0.6× 92 0.2× 518 1.4× 131 0.4× 41 1.6k
Patrizia Bossolasco Italy 20 893 1.6× 193 0.5× 145 0.4× 131 0.4× 343 0.9× 40 2.1k
Karina T. Wright United Kingdom 19 419 0.7× 109 0.3× 57 0.2× 187 0.5× 319 0.9× 61 2.0k
Marco Campisi United States 11 648 1.1× 257 0.7× 98 0.3× 604 1.6× 167 0.5× 14 1.6k
Shiwen Zhang China 22 893 1.6× 197 0.5× 74 0.2× 332 0.9× 80 0.2× 59 1.9k
Valérie Vanneaux France 27 1.2k 2.1× 164 0.4× 218 0.6× 387 1.0× 99 0.3× 58 2.3k
Seuk Young Song South Korea 18 890 1.6× 251 0.7× 79 0.2× 772 2.1× 74 0.2× 25 2.0k
Yiqian Zhu China 19 575 1.0× 142 0.4× 81 0.2× 323 0.9× 229 0.6× 37 1.7k
Jinhai Ye China 26 1.4k 2.4× 654 1.7× 109 0.3× 245 0.7× 75 0.2× 73 2.3k

Countries citing papers authored by Xiuxing Chen

Since Specialization
Citations

This map shows the geographic impact of Xiuxing Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiuxing Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiuxing Chen more than expected).

Fields of papers citing papers by Xiuxing Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiuxing Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiuxing Chen. The network helps show where Xiuxing Chen may publish in the future.

Co-authorship network of co-authors of Xiuxing Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Xiuxing Chen. A scholar is included among the top collaborators of Xiuxing Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiuxing Chen. Xiuxing Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
3.
Gong, Yihang, Wen-Jie Chen, Xiuxing Chen, et al.. (2022). An Injectable Epigenetic Autophagic Modulatory Hydrogel for Boosting Umbilical Cord Blood NK Cell Therapy Prevents Postsurgical Relapse of Triple‐Negative Breast Cancer. Advanced Science. 9(23). e2201271–e2201271. 42 indexed citations
4.
Fan, Lei, Can Liu, Xiuxing Chen, et al.. (2022). Exosomes‐Loaded Electroconductive Hydrogel Synergistically Promotes Tissue Repair after Spinal Cord Injury via Immunoregulation and Enhancement of Myelinated Axon Growth. Advanced Science. 9(13). e2105586–e2105586. 286 indexed citations breakdown →
5.
Jiang, Qi, Jinsheng Huang, Bei Zhang, et al.. (2022). Efficacy and Safety of Anti-PD1/PDL1 in Advanced Biliary Tract Cancer: A Systematic Review and Meta-Analysis. Frontiers in Immunology. 13. 801909–801909. 8 indexed citations
6.
Chen, Xiuxing, Ziming Du, De‐Shen Wang, et al.. (2021). Circulating PD-L1 is associated with T cell infiltration and predicts prognosis in patients with CRLM following hepatic resection. Cancer Immunology Immunotherapy. 71(3). 661–674. 21 indexed citations
8.
Wang, Yun, Xiuxing Chen, Haocheng Lin, et al.. (2021). A Prehepatectomy Circulating Exosomal microRNA Signature Predicts the Prognosis and Adjuvant Chemotherapeutic Benefits in Colorectal Liver Metastasis. Cancers. 13(17). 4258–4258. 7 indexed citations
9.
Liang, Jie‐Ying, De‐Shen Wang, Haocheng Lin, et al.. (2020). A Novel Ferroptosis-related Gene Signature for Overall Survival Prediction in Patients with Hepatocellular Carcinoma. International Journal of Biological Sciences. 16(13). 2430–2441. 413 indexed citations breakdown →
10.
Quan, Qi, Yixing Wang, Feng‐Hua Wang, et al.. (2020). Real World First-Line Treatments and Outcomes of Nab-Paclitaxel Plus Gemcitabine, mFOLFIRINOX and GEMOX in Unresectable Pancreatic Cancer from a Chinese Single Institution. Current Oncology. 28(1). 209–219. 2 indexed citations
11.
Guo, Guifang, Xiuxing Chen, Xiuyu Cai, et al.. (2019). Inflammation-based markers can predict the prognosis of geriatric patients with metastatic colorectal cancer receiving first-line chemotherapy. Translational Cancer Research. 8(4). 1137–1147. 9 indexed citations
12.
Guo, Guifang, Yixing Wang, Yijun Zhang, et al.. (2019). Predictive and prognostic implications of 4E-BP1, Beclin-1, and LC3 for cetuximab treatment combined with chemotherapy in advanced colorectal cancer with wild-type KRAS: Analysis from real-world data. World Journal of Gastroenterology. 25(15). 1840–1853. 25 indexed citations
13.
Fan, Lei, et al.. (2019). Surgery vs conservative treatment for type II and III odontoid fractures in a geriatric population. Medicine. 98(44). e10281–e10281. 17 indexed citations
14.
Guo, Guifang, Xiuxing Chen, Wenzhuo He, et al.. (2018). Establishment of inflammation biomarkers-based nomograms to predict prognosis of advanced colorectal cancer patients based on real world data. PLoS ONE. 13(12). e0208547–e0208547. 14 indexed citations
15.
Zhou, Lei, Lei Fan, Yi Xin, et al.. (2018). Soft Conducting Polymer Hydrogels Cross-Linked and Doped by Tannic Acid for Spinal Cord Injury Repair. ACS Nano. 12(11). 10957–10967. 321 indexed citations breakdown →
16.
Wang, Haohua, Roujun Peng, Xiuxing Chen, et al.. (2018). Effect of HK2, PKM2 and LDHA on Cetuximab efficacy in metastatic colorectal cancer. Oncology Letters. 15(4). 5553–5560. 16 indexed citations
17.
Fan, Lei, Can Liu, Xiuxing Chen, et al.. (2018). Directing Induced Pluripotent Stem Cell Derived Neural Stem Cell Fate with a Three-Dimensional Biomimetic Hydrogel for Spinal Cord Injury Repair. ACS Applied Materials & Interfaces. 10(21). 17742–17755. 217 indexed citations
18.
Guo, Guifang, Xiuxing Chen, Yanfeng Chen, et al.. (2017). Efficacy and safety of bevacizumab in elderly patients with advanced colorectal cancer: A meta-analysis. Journal of Cancer Research and Therapeutics. 13(5). 869–869. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026